Beijing Wantai Biological Pharmacy Enterprise Co. Investor Relations Material
Latest events
Q1 2025
25 Apr, 2025
Q4 2024
12 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd
Access all reports
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. specializes in the research, development, production, and distribution of biopharmaceutical products. The company focuses on diagnostic reagents, vaccines, and other biological products used in the prevention and detection of infectious diseases. Its offerings serve healthcare institutions, laboratories, and public health organizations, aiming to support disease prevention and health management. The company is headquartered in Beijing, China, and its shares are listed on the SSE.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
603392
Country
🇨🇳 China